{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:42:54Z","timestamp":1761561774093},"reference-count":112,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.2217\/imt.13.66","type":"journal-article","created":{"date-parts":[[2013,7,5]],"date-time":"2013-07-05T15:21:17Z","timestamp":1373037677000},"page":"743-754","source":"Crossref","is-referenced-by-count":13,"title":["Approaches to Immunosuppression in Beh\u00e7et\u2018s Disease"],"prefix":"10.1080","volume":"5","author":[{"given":"Clo\u00e9","family":"Comarmond","sequence":"first","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re, Service de M\u00e9decine Interne 2, Universit\u00e9 Pierre et Marie Curie-Paris VI, 83 Boulevard de l'H\u00f4pital, 75013Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Wechsler","sequence":"additional","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re, Service de M\u00e9decine Interne 2, Universit\u00e9 Pierre et Marie Curie-Paris VI, 83 Boulevard de l'H\u00f4pital, 75013Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Cacoub","sequence":"additional","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re, Service de M\u00e9decine Interne 2, Universit\u00e9 Pierre et Marie Curie-Paris VI, 83 Boulevard de l'H\u00f4pital, 75013Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Saadoun","sequence":"additional","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re, Service de M\u00e9decine Interne 2, Universit\u00e9 Pierre et Marie Curie-Paris VI, 83 Boulevard de l'H\u00f4pital, 75013Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2013,7,5]]},"reference":[{"key":"e_1_3_2_3_1_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199910213411707"},{"issue":"8697","key":"e_1_3_2_3_2_1","first-page":"1078","volume":"335","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2018s Disease. Criteria for diagnosis of Beh\u00e7et\u2018s disease. Lancet.335(8697) , 1078\u20131080 (1990).","journal-title":"Lancet."},{"key":"e_1_3_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.37715"},{"key":"e_1_3_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12107"},{"key":"e_1_3_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.3109\/08830189709116843"},{"issue":"2","key":"e_1_3_2_3_6_1","first-page":"259","volume":"30","author":"Yazici H","year":"1977","unstructured":"Yazici H , AkokanG, Yal\u00e7inB, M\u00fcft\u00fcogluA. The high prevalence of HLA-B5 in Beh\u00e7et\u2018s disease. Clin. Exp. Immunol.30(2) , 259\u2013261 (1977).","journal-title":"Clin. Exp. Immunol."},{"key":"e_1_3_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24642"},{"key":"e_1_3_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.1992.tb04888.x"},{"key":"e_1_3_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27568"},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.080432"},{"key":"e_1_3_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.087957"},{"key":"e_1_3_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e318211bf28"},{"key":"e_1_3_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H"},{"key":"e_1_3_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-128-6-199803150-00004"},{"key":"e_1_3_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3181dfca14"},{"key":"e_1_3_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-124-10-199605150-00005"},{"key":"e_1_3_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2002.tb00263.x"},{"issue":"3","key":"e_1_3_2_3_18_1","first-page":"399","article-title":"A double blind study of colchicine in Beh\u00e7et\u2018s disease.","volume":"65","author":"Aktulga E","year":"1980","unstructured":"Aktulga E , Alta\u00e7M, M\u00fcft\u00fcogluA et al. A double blind study of colchicine in Beh\u00e7et\u2018s disease. Haematologica 65(3) , 399\u2013402 (1980).","journal-title":"Haematologica"},{"issue":"6","key":"e_1_3_2_3_19_1","first-page":"1098","article-title":"Systemic interferon alpha 2b treatment in Beh\u00e7et\u2018s syndrome.","volume":"21","author":"Hamuryudan V","year":"1994","unstructured":"Hamuryudan V , MoralF, YurdakulS et al. Systemic interferon alpha 2b treatment in Beh\u00e7et\u2018s syndrome. J. Rheumatol. 21(6) , 1098\u20131100 (1994).","journal-title":"J. Rheumatol."},{"key":"e_1_3_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199002013220501"},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2010.09.002"},{"key":"e_1_3_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3182431d56"},{"key":"e_1_3_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24393"},{"key":"e_1_3_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/0-306-48382-3_118"},{"key":"e_1_3_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-011-1726-1"},{"key":"e_1_3_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/0-306-48382-3_117"},{"key":"e_1_3_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2011.09.006"},{"key":"e_1_3_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.3.614"},{"key":"e_1_3_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-200406000-00017"},{"key":"e_1_3_2_3_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3182428f49"},{"key":"e_1_3_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3182428126"},{"key":"e_1_3_2_3_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.34450"},{"key":"e_1_3_2_3_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200301000-00006"},{"key":"e_1_3_2_3_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20308"},{"key":"e_1_3_2_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)72840-5"},{"key":"e_1_3_2_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05497-6"},{"key":"e_1_3_2_3_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21231"},{"key":"e_1_3_2_3_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2009.158840"},{"key":"e_1_3_2_3_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400425"},{"key":"e_1_3_2_3_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2008.08.038"},{"key":"e_1_3_2_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(98)00165-8"},{"issue":"4","key":"e_1_3_2_3_42_1","first-page":"185","volume":"89","author":"Chan WP","year":"2012","unstructured":"Chan WP , Lee H-S. Combination therapy with infliximab and methotrexate in recalcitrant mucocutaneous Beh\u00e7et disease. Cutis89(4) , 185\u2013190 (2012).","journal-title":"Cutis"},{"key":"e_1_3_2_3_43_1","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-010-0370-y"},{"key":"e_1_3_2_3_44_1","first-page":"S94","volume":"28","author":"Atzeni F","year":"2010","unstructured":"Atzeni F , LecceseP, D\u2018AngeloS, Sarzi-PuttiniP, OlivieriI. Successful treatment of leg ulcers in Beh\u00e7et\u2018s disease using adalimumab plus methotrexate after the failure of infliximab. Clin. Exp. Rheumatol.28(4 Suppl. 60) , S94 (2010).","journal-title":"Clin. Exp. Rheumatol."},{"key":"e_1_3_2_3_45_1","doi-asserted-by":"publisher","DOI":"10.1159\/000051781"},{"key":"e_1_3_2_3_46_1","first-page":"S64","volume":"29","author":"Shugaiv E","year":"2011","unstructured":"Shugaiv E , T\u00fcz\u00fcnE, MutluM, Kiyat-AtamerA, KurtuncuM, Akman-DemirG. Mycophenolate mofetil as a novel immunosuppressant in the treatment of neuro-Beh\u00e7et\u2018s disease with parenchymal involvement: presentation of four cases. Clin. Exp. Rheumatol.29(4 Suppl. 67) , S64\u2013S67 (2011).","journal-title":"Clin. Exp. Rheumatol."},{"key":"e_1_3_2_3_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2010.12.002"},{"key":"e_1_3_2_3_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-006-0385-0"},{"key":"e_1_3_2_3_49_1","doi-asserted-by":"publisher","DOI":"10.1159\/000056324"},{"key":"e_1_3_2_3_50_1","first-page":"136","article-title":"Evaluation of conventional therapy versus cyclosporine A in Beh\u00e7et\u2018s syndrome.","volume":"20","author":"BenEzra D","year":"1988","unstructured":"BenEzra D , CohenE, ChajekT et al. Evaluation of conventional therapy versus cyclosporine A in Beh\u00e7et\u2018s syndrome. Transplant. Proc. 20(3 Suppl. 4) , 136\u2013143 (1988).","journal-title":"Transplant. Proc."},{"key":"e_1_3_2_3_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-005-0070-8"},{"key":"e_1_3_2_3_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90120-3"},{"key":"e_1_3_2_3_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00407749"},{"key":"e_1_3_2_3_54_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.4.467"},{"key":"e_1_3_2_3_55_1","doi-asserted-by":"publisher","DOI":"10.1159\/000246374"},{"issue":"5","key":"e_1_3_2_3_56_1","first-page":"896","volume":"35","author":"Krause L","year":"2008","unstructured":"Krause L , AltenburgA, PleyerU, K\u00f6hler A-K, Zouboulis CC, Foerster MH. Longterm visual prognosis of patients with ocular Adamantiades-Beh\u00e7et\u2018s disease treated with interferon-alpha-2a. J. Rheumatol.35(5) , 896\u2013903 (2008).","journal-title":"J. Rheumatol."},{"key":"e_1_3_2_3_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2003.09.010"},{"key":"e_1_3_2_3_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27581"},{"key":"e_1_3_2_3_59_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2003.037192"},{"key":"e_1_3_2_3_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0755-4982(05)84079-5"},{"key":"e_1_3_2_3_61_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.025882"},{"key":"e_1_3_2_3_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-1213-z"},{"key":"e_1_3_2_3_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-006-0425-y"},{"key":"e_1_3_2_3_64_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.2912"},{"key":"e_1_3_2_3_65_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2007.127522"},{"key":"e_1_3_2_3_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2007.01796.x"},{"key":"e_1_3_2_3_67_1","first-page":"928","volume":"4","author":"Hamuryudan V","year":"2002","unstructured":"Hamuryudan V , OzyazganY, FreskoY, MatC, YurdakulS, YaziciH. Interferon alfa combined with azathioprine for the uveitis of Beh\u00e7et\u2018s disease: an open study. Isr. Med. Assoc. J.4(Suppl. 11) , 928\u2013930 (2002).","journal-title":"Isr. Med. Assoc. J."},{"key":"e_1_3_2_3_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2003.09.005"},{"key":"e_1_3_2_3_69_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken172"},{"key":"e_1_3_2_3_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6702352"},{"key":"e_1_3_2_3_71_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-009-1272-2"},{"key":"e_1_3_2_3_72_1","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20869"},{"key":"e_1_3_2_3_73_1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2012.741744"},{"issue":"1","key":"e_1_3_2_3_74_1","first-page":"98","article-title":"Short-term trial of etanercept in Beh\u00e7et\u2018s disease: a double blind, placebo controlled study.","volume":"32","author":"Melikoglu M","year":"2005","unstructured":"Melikoglu M , FreskoI, MatC et al. Short-term trial of etanercept in Beh\u00e7et\u2018s disease: a double blind, placebo controlled study. J. Rheumatol. 32(1) , 98\u2013105 (2005).","journal-title":"J. Rheumatol."},{"key":"e_1_3_2_3_75_1","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1423.050"},{"issue":"7","key":"e_1_3_2_3_76_1","first-page":"1362","article-title":"Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Beh\u00e7et\u2018s disease with refractory uveoretinitis.","volume":"31","author":"Ohno S","year":"2004","unstructured":"Ohno S , NakamuraS, HoriS et al. Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Beh\u00e7et\u2018s disease with refractory uveoretinitis. J. Rheumatol. 31(7) , 1362\u20131368 (2004).","journal-title":"J. Rheumatol."},{"key":"e_1_3_2_3_77_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2012-302515"},{"key":"e_1_3_2_3_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2008.09.010"},{"key":"e_1_3_2_3_79_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-5-200403020-00025"},{"key":"e_1_3_2_3_80_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-006-9006-9"},{"key":"e_1_3_2_3_81_1","doi-asserted-by":"publisher","DOI":"10.1177\/112067210401400515"},{"key":"e_1_3_2_3_82_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep126"},{"key":"e_1_3_2_3_83_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem101"},{"key":"e_1_3_2_3_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-008-0606-8"},{"key":"e_1_3_2_3_85_1","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2011.2698"},{"key":"e_1_3_2_3_86_1","first-page":"S62","volume":"30","author":"Furuta S","year":"2012","unstructured":"Furuta S , ChowYW, ChaudhryAN, JayneD. Switching of anti-TNF-\u03b1 agents in Beh\u00e7et\u2018s disease. Clin. Exp. Rheumatol.30(3 Suppl. 72) , S62\u2013S68 (2012).","journal-title":"Clin. Exp. Rheumatol."},{"key":"e_1_3_2_3_87_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-1178-y"},{"key":"e_1_3_2_3_88_1","doi-asserted-by":"publisher","DOI":"10.1157\/13083329"},{"issue":"10","key":"e_1_3_2_3_89_1","first-page":"1428","volume":"17","author":"Hamzaoui K","year":"1990","unstructured":"Hamzaoui K , HamzaM, AyedK. Production of TNF-alpha and IL-1 in active Beh\u00e7et\u2018s disease. J. Rheumatol.17(10) , 1428\u20131429 (1990).","journal-title":"J. Rheumatol."},{"key":"e_1_3_2_3_90_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-4-200808190-00018"},{"key":"e_1_3_2_3_91_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-155143"},{"key":"e_1_3_2_3_92_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201383"},{"key":"e_1_3_2_3_93_1","first-page":"S115","volume":"30","author":"Cantarini L","year":"2012","unstructured":"Cantarini L , VitaleA, BorriM, GaleazziM, FranceschiniR. Successful use of canakinumab in a patient with resistant Beh\u00e7et\u2018s disease. Clin. Exp. Rheumatol.30(3 Suppl. 72) , S115 (2012).","journal-title":"Clin. Exp. Rheumatol."},{"key":"e_1_3_2_3_94_1","doi-asserted-by":"publisher","DOI":"10.1080\/030097402320318387"},{"key":"e_1_3_2_3_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2008.10.007"},{"key":"e_1_3_2_3_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2011.10.024"},{"key":"e_1_3_2_3_97_1","first-page":"S73","volume":"30","author":"Urbaniak P","year":"2012","unstructured":"Urbaniak P , HaslerP, KretzschmarS. Refractory neuro-Beh\u00e7et treated by tocilizumab: a case report. Clin. Exp. Rheumatol.30(3 Suppl. 72) , S73\u2013S75 (2012).","journal-title":"Clin. Exp. Rheumatol."},{"key":"e_1_3_2_3_98_1","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-011-0497-5"},{"key":"e_1_3_2_3_99_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1756-185X.2010.01546.x"},{"key":"e_1_3_2_3_100_1","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-008-0057-9"},{"key":"e_1_3_2_3_101_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e318284735c"},{"key":"e_1_3_2_3_102_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg424"},{"key":"e_1_3_2_3_103_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273940701299370"},{"key":"e_1_3_2_3_104_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.035410"},{"key":"e_1_3_2_3_105_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.056630"},{"key":"e_1_3_2_3_106_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200101043440121"},{"key":"e_1_3_2_3_107_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.070227"},{"key":"e_1_3_2_3_108_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei165"},{"key":"e_1_3_2_3_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.11.022"},{"key":"e_1_3_2_3_110_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-012-0182-z"},{"key":"e_1_3_2_3_111_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2010.194464"},{"key":"e_1_3_2_3_112_1","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-011-0585-6"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt.13.66","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T01:17:05Z","timestamp":1715995025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt.13.66"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":112,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["10.2217\/imt.13.66"],"URL":"https:\/\/doi.org\/10.2217\/imt.13.66","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}